Who Holds Biocryst Pharmaceuticals Inc (BCRX)? 318 Institutional Holders, Q2 2026
Managers with more than $100 million in US equities report their holdings on Form 13F within 45 days of each quarter end. Quarter ended 30 Jun 2026: 318 holders, $2.6 billion in total.
Largest holders
The 100 largest by value. Change in shares against Q1 2026.
| Manager | Shares | Value | Change | |
|---|---|---|---|---|
| BlackRock, Inc. | 23,893,036 | $239 million | +5% | 13F |
| RA CAPITAL MANAGEMENT, L.P. | 15,827,186 | $158 million | +0% | 13F |
| STATE STREET CORP | 15,191,098 | $152 million | +24% | 13F |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 15,096,403 | $151 million | +0% | 13F |
| VANGUARD CAPITAL MANAGEMENT LLC | 11,364,236 | $114 million | +2% | 13F |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 11,139,158 | $111 million | -1% | 13F |
| TCG Crossover Management, LLC | 11,020,968 | $110 million | +0% | 13F |
| PERCEPTIVE ADVISORS LLC | 10,308,888 | $103 million | +39% | 13F |
| Jupiter Topco LLC | 9,540,764 | $95 million | New | 13F |
| Vestal Point Capital, LP | 8,300,000 | $83 million | +18% | 13F |
| TWO SIGMA INVESTMENTS, LP | 6,775,349 | $68 million | +6% | 13F |
| GEODE CAPITAL MANAGEMENT, LLC | 6,248,046 | $62 million | +8% | 13F |
| Aberdeen Group plc | 5,310,871 | $53 million | +5% | 13F |
| UBS Group AG | 5,078,280 | $51 million | +3% | 13F |
| BANK OF AMERICA CORP /DE/ | 4,801,284 | $48 million | -6% | 13F |
| GOLDMAN SACHS GROUP INC | 4,481,874 | $45 million | +91% | 13F |
| Frazier Life Sciences Management, L.P. | 4,009,240 | $40 million | +0% | 13F |
| Nuveen, LLC | 4,007,237 | $40 million | +5% | 13F |
| MILLENNIUM MANAGEMENT LLC | 3,394,729 | $34 million | +1708% | 13F |
| JANE STREET GROUP, LLC | 2,762,683 | $28 million | +344% | 13F |
| DIMENSIONAL FUND ADVISORS LP | 2,718,781 | $27 million | +1% | 13F |
| Fisher Asset Management, LLC | 2,604,027 | $26 million | -5% | 13F |
| RENAISSANCE TECHNOLOGIES LLC | 2,530,290 | $25 million | +226% | 13F |
| Kynam Capital Management, LP | 2,522,660 | $25 million | -56% | 13F |
| Candriam S.C.A. | 2,514,949 | $25 million | +10% | 13F |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2,353,291 | $24 million | +0% | 13F |
| RICE HALL JAMES & ASSOCIATES, LLC | 2,332,043 | $23 million | +5% | 13F |
| NORTHERN TRUST CORP | 2,255,731 | $23 million | +7% | 13F |
| AQR CAPITAL MANAGEMENT LLC | 2,214,302 | $22 million | +403% | 13F |
| MORGAN STANLEY | 1,999,684 | $20 million | -1% | 13F |
| Nantahala Capital Management, LLC | 1,901,160 | $19 million | -4% | 13F |
| Eversept Partners, LP | 1,865,653 | $19 million | -39% | 13F |
| ORBIMED ADVISORS LLC | 1,852,000 | $19 million | +30% | 13F |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 1,844,912 | $18 million | +50% | 13F |
| STIFEL FINANCIAL CORP | 1,826,234 | $18 million | +0% | 13F |
| VANGUARD FIDUCIARY TRUST CO | 1,759,573 | $18 million | +6% | 13F |
| CITADEL ADVISORS LLC | 1,759,160 | $18 million | +73% | 13F |
| JUPITER ASSET MANAGEMENT LTD | 1,642,874 | $16 million | +37% | 13F |
| IMC-Chicago, LLC | 1,634,336 | $16 million | +159% | 13F |
| Parkman Healthcare Partners LLC | 1,624,279 | $16 million | -5% | 13F |
| Legal & General Group Plc | 1,455,514 | $15 million | +3% | 13F |
| OP Asset Management Ltd | 1,340,990 | $13 million | +7% | 13F |
| Invesco Ltd. | 1,233,783 | $12 million | -6% | 13F |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1,195,651 | $12 million | -58% | 13F |
| Pictet Asset Management Holding SA | 1,249,771 | $12 million | +165% | 13F |
| BNP PARIBAS FINANCIAL MARKETS | 1,174,052 | $12 million | -10% | 13F |
| FIRST TRUST ADVISORS LP | 1,120,469 | $11 million | +40% | 13F |
| MOORE CAPITAL MANAGEMENT, LP | 848,336 | $8 million | New | 13F |
| FMR LLC | 808,903 | $8 million | +28% | 13F |
| ExodusPoint Capital Management, LP | 744,917 | $7 million | +292% | 13F |
| Man Group plc | 732,867 | $7 million | -43% | 13F |
| Rosalind Advisors, Inc. | 721,504 | $7 million | -22% | 13F |
| Schonfeld Strategic Advisors LLC | 710,816 | $7 million | -47% | 13F |
| Bank of New York Mellon Corp | 680,481 | $7 million | +7% | 13F |
| Jump Financial, LLC | 569,956 | $6 million | +421% | 13F |
| DEUTSCHE BANK AG\ | 563,361 | $6 million | -31% | 13F |
| VOYA INVESTMENT MANAGEMENT LLC | 538,813 | $5 million | +0% | 13F |
| Elmind Capital, LP | 520,000 | $5 million | -48% | 13F |
| JPMORGAN CHASE & CO | 525,449 | $5 million | -66% | 13F |
| Bridgewater Associates, LP | 491,057 | $5 million | -23% | 13F |
| FRANKLIN RESOURCES INC | 480,364 | $5 million | -8% | 13F |
| PRINCIPAL FINANCIAL GROUP INC | 468,785 | $5 million | +9% | 13F |
| NAN FUNG TRINITY (HK) LTD | 450,000 | $5 million | New | 13F |
| SPHERA FUNDS MANAGEMENT LTD. | 422,051 | $4 million | -51% | 13F |
| Swiss National Bank | 415,268 | $4 million | +2% | 13F |
| D. E. Shaw & Co., Inc. | 408,529 | $4 million | +35% | 13F |
| Susquehanna Portfolio Strategies, LLC | 404,704 | $4 million | +8% | 13F |
| DAFNA Capital Management LLC | 400,248 | $4 million | -7% | 13F |
| Hudson Bay Capital Management LP | 400,000 | $4 million | -18% | 13F |
| WEDGE CAPITAL MANAGEMENT L L P/NC | 380,801 | $4 million | New | 13F |
| DOLIVER ADVISORS, LP | 374,328 | $4 million | +0% | 13F |
| Aquatic Capital Management LLC | 362,895 | $4 million | New | 13F |
| CITIGROUP INC | 360,189 | $4 million | +406% | 13F |
| Assenagon Asset Management S.A. | 353,044 | $4 million | +52% | 13F |
| MACKENZIE FINANCIAL CORP | 347,299 | $3 million | +43% | 13F |
| Phocas Financial Corp. | 340,541 | $3 million | +74% | 13F |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 320,566 | $3 million | -13% | 13F |
| ALPS ADVISORS INC | 317,960 | $3 million | +428% | 13F |
| ALLIANCEBERNSTEIN L.P. | 327,909 | $3 million | +24% | 13F |
| WELLINGTON MANAGEMENT GROUP LLP | 293,925 | $3 million | +197% | 13F |
| RHUMBLINE ADVISERS | 279,839 | $3 million | +5% | 13F |
| NFJ INVESTMENT GROUP, LLC | 278,792 | $3 million | New | 13F |
| Rafferty Asset Management, LLC | 265,618 | $3 million | -25% | 13F |
| Point72 Asset Management, L.P. | 260,917 | $3 million | New | 13F |
| WINTON GROUP Ltd | 255,600 | $3 million | +380% | 13F |
| MARSHALL WACE, LLP | 252,764 | $3 million | +3% | 13F |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 251,230 | $3 million | -3% | 13F |
| MARTINGALE ASSET MANAGEMENT L P | 242,508 | $2 million | +329% | 13F |
| IEQ CAPITAL, LLC | 227,421 | $2 million | New | 13F |
| WELLS FARGO & COMPANY/MN | 222,894 | $2 million | -6% | 13F |
| HUSSMAN STRATEGIC ADVISORS, INC. | 210,000 | $2 million | New | 13F |
| PFM Health Sciences, LP | 207,357 | $2 million | New | 13F |
| VANGUARD ASSET MANAGEMENT, Ltd | 196,280 | $2 million | +0% | 13F |
| TUDOR INVESTMENT CORP ET AL | 195,128 | $2 million | New | 13F |
| Engineers Gate Manager LP | 175,002 | $2 million | -10% | 13F |
| Squarepoint Ops LLC | 174,714 | $2 million | +339% | 13F |
| QTR Family Wealth, LLC | 161,082 | $2 million | +3% | 13F |
| Gotham Asset Management, LLC | 156,421 | $2 million | -50% | 13F |
| RAYMOND JAMES FINANCIAL INC | 155,544 | $2 million | -3% | 13F |
| Corient Private Wealth LP | 150,447 | $2 million | +58% | 13F |
Questions and answers
- How many institutions hold Biocryst Pharmaceuticals Inc?
- 318 managers reported Biocryst Pharmaceuticals Inc on Form 13F for the quarter ended 30 June 2026, against 302 the quarter before.
- Who is the largest institutional holder of Biocryst Pharmaceuticals Inc?
- BlackRock, Inc., with 23,893,036 shares worth $239 million on its 13F for Q2 2026.
- How many institutions bought or sold out of Biocryst Pharmaceuticals Inc in Q2 2026?
- 56 managers reported a new position and 40 reported none after holding it the quarter before.
Source: SEC EDGAR, Form 13F (public domain). Counts and values as filed. Cite this page: Tamarly Intelligence, "Who holds Biocryst Pharmaceuticals Inc, Q2 2026", https://app.tamarly.ai/holders/biocryst-pharmaceuticals, built from SEC EDGAR.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.